. Author manuscript; available in PMC: 2014 Sep 1.

Published in final edited form as: Behav Genet. 2013 Aug 14;43(5):10.1007/s10519-013-9606-x. doi: 10.1007/s10519-013-9606-x

Table 2.

SNPs associated with one clinical phenotype at p < E-05 that were also associated with at least one other clinical phenotype at p < E-03.

Locus Information for Associated SNPs							Alcohol Consumption		Alcohol Dependence		Illicit Drugs		Nicotine		Behavioral Disinhibition

SNP	CHR	BP(Build 37.3)	SNP Class	Gene	MA	MAF	Beta	p	Beta	p	Beta	p	Beta	p	Beta	p
rs1296438	1p32.3	53,937,177	Flanking 3’	GLIS1	G	.26	2.05	1.3e^-2	.25	2.3e^-3	8.22	1.0e^-4	5.87	7.9e^-6	1.37	6.2e^-4
rs1298637	1p32.3	53,958,603	Flanking 3’	GLIS1	A	.26	2.11	1.1e^-2	.25	1.7e^-3	7.97	1.6e^-4	5.97	5.3e^-6	1.42	3.8e^-4
rs1368882	1p32.3	55,107,019	Flanking 5’	GLIS1	A	.38	1.84	1.5e^-2	.27	2.9e^-4	4.90	1.2e^-2	4.46	2.1e^-4	1.75	1.9e^-6
rs10926554	1q43	241,894,086	Intron	WDR64	A	.13	-2.73	1.3e^-2	-.35	1.0e^-3	-13.13	3.3e^-6	-7.02	5.9e^-5	-2.00	1.8e^-4
rs6712333	2q37.1	231,230,171	Intron	SP140L	A	.12	3.52	2.3e^-3	.45	6.1e^-5	9.86	8.3e^-4	8.32	5.3e^-6	1.55	5.4e^-3
rs7620363	3p22.3	34,013,205	Intergenic		A	.35	-2.62	7.1e^-4	-.23	2.4e^-3	-6.49	1.0e^-3	-4.31	4.6e^-4	-1.66	9.2e^-6
rs11918665	3q27.3	186,213,784	Flanking 3’	CRYGS	A	.13	3.82	5.5e^-4	.29	7.0e^-3	15.03	1.1e^-7	6.20	4.2e^-4	1.98	2.2e^-4
rs1868152	3q27.3	186,220,063	Flanking 3’	CRYGS	A	.12	3.81	7.0e^-4	.30	5.6e^-3	15.68	4.9e^-8	6.61	2.2e^-4	2.26	3.5e^-5
rs4440177	4q32.2	163,243,053	Intergenic		A	.34	2.68	6.6e^-4	.35	6.3e^-6	8.15	5.3e^-5	4.42	4.1e^-4	1.23	1.3e^-3
rs13259289	8p23.2	4,110,032	Intron	CSMD1	G	.40	-2.76	2.2e^-4	-.25	5.3e^-4	-8.68	5.9e^-6	-2.85	1.7e^-2	-1.45	6.4e^-5
rs804292	8p23.1	11,643,915	3’ UTR	NEIL2	G	.23	-2.88	1.1e^-3	-.41	1.6e^-6	-9.00	6.8e^-5	-6.53	3.4e^-6	-1.62	1.5e^-4
rs1793257	11q25	12,584,119	Intron	OPCML	A	.04	0.75	6.9e^-1	.83	7.4e^-6	14.10	3.7e^-3	7.51	1.3e^-2	3.23	4.6e^-4
rs4788985	17q25.2	75,313,335	Flanking 5’	SEPT9	G	.49	2.46	7.8e^-4	.18	1.2e^-2	8.35	8.9e^-6	4.37	1.8e^-4	1.04	3.5e^-3